Infralimbic Endothelin1 Is Critical for the Modulation of Anxiety-Like Behaviors

Lin-Lin Bi,Ming Chen,Lei Pei,Shu Shu,Hui-Juan Jin,Hong-Lin Yan,Na Wei,Shan Wang,Xin Yang,Huan-Huan Yan,Meng-Meng Xu,Cheng-Ye Yao,Na Li,Na Tang,Jian-Hua Wu,Hou-Ze Zhu,Hao Li,You Cai,Yu Guo,Yan Shi,Qing Tian,Ling-Qiang Zhu,You-Ming Lu
DOI: https://doi.org/10.1007/s12035-015-9163-9
Abstract:Endothelin1 (ET1) is a potent vasoconstrictor that is also known to be a neuropeptide that is involved in neural circuits. We examined the role of ET1 that has been implicated in the anxiogenic process. We found that infusing ET1 into the IL cortex increased anxiety-like behaviors. The ET(A) receptor (ET(A)R) antagonist (BQ123) but not the ET(B) receptor (ET(B)R) antagonist (BQ788) alleviated ET1-induced anxiety. ET1 had no effect on GABAergic neurotransmission or NMDA receptor (NMDAR)-mediated neurotransmission, but increased AMPA receptor (AMPAR)-mediated excitatory synaptic transmission. The changes in AMPAR-mediated excitatory postsynaptic currents were due to presynaptic mechanisms. Finally, we found that the AMPAR antagonists (CNQX) and BQ123 reversed ET1's anxiogenic effect, with parallel and corresponding electrophysiological changes. Moreover, infusing CNQX + BQ123 into the IL had no additional anxiolytic effect compared to CNQX treatment alone. Altogether, our findings establish a previously unknown anxiogenic action of ET1 in the IL cortex. AMPAR-mediated glutamatergic neurotransmission may underlie the mechanism of ET1-ET(A)R signaling pathway in the regulation of anxiety.
What problem does this paper attempt to address?